| 000 | 01564 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513120254.0 | ||
| 264 | 0 | _c19970717 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0277-6715 | ||
| 024 | 7 |
_a10.1002/(sici)1097-0258(19970430)16:8<951::aid-sim547>3.0.co;2-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFinkelstein, D M | |
| 245 | 0 | 0 |
_aAnalysis of multiple failure time data from an AIDS clinical trial. _h[electronic resource] |
| 260 |
_bStatistics in medicine _cApr 1997 |
||
| 300 |
_a951-61 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xmortality |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCandidiasis _xdrug therapy |
| 650 | 0 | 4 |
_aClinical Trials, Phase III as Topic _xmethods |
| 650 | 0 | 4 |
_aClotrimazole _xtherapeutic use |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 |
_aFluconazole _xtherapeutic use |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aSchoenfeld, D A | |
| 700 | 1 | _aStamenovic, E | |
| 773 | 0 |
_tStatistics in medicine _gvol. 16 _gno. 8 _gp. 951-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0258(19970430)16:8<951::aid-sim547>3.0.co;2-5 _zAvailable from publisher's website |
| 999 |
_c9141729 _d9141729 |
||